BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:37 PM
 | 
Jul 24, 2009
 |  BC Extra  |  Top Story

Rigel down on Phase IIb miss

On Friday, Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) fell $1.13 (10%) to $10.43 after announcing late Thursday that fostamatinib missed the primary and secondary endpoints in a Phase IIb trial to treat rheumatoid arthritis. In the...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >